started · updated
Hospital for Special Surgery researchers develop new rheumatoid arthritis inflammation assessments
Investigators at the Hospital for Special Surgery (HSS) have conducted three studies aimed at improving how joint inflammation is assessed in patients with rheumatoid arthritis (RA). The research, presented by rheumatologist Melanie H. Smith at the American College of Rheumatology annual meeting, seeks to move toward precision medicine by using a patient’s unique biological characteristics to guide treatment decisions.
Currently, finding effective medication for RA often involves a lengthy trial-and-error process that can last months or years. Because the disease manifests differently in each individual, some patients exhibit high numbers of specific immune cells in their joint lining, while others do not. By better identifying these distinctive biological markers, clinicians hope to predict how a patient will respond to specific medications, thereby reducing the time spent on ineffective treatments.
Entities
American College of Rheumatology · Hospital for Special Surgery · Melanie H. Smith